Prednicarbate Cream
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Prednicarbate Cream contains NLT 90.0% and NMT 110.0% of the labeled amount of prednicarbate (C27H36O8). It may contain a suitable preservative.
2 IDENTIFICATION
A. The retention time of the prednicarbate peak in the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
3.1 Procedure
Solution A: 0.01 M monobasic potassium phosphate
Solution B: Acetonitrile and dehydrated alcohol (2:1)
Mobile phase: See Table 1.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
| 0 | 67 | 33 |
| 5 | 67 | 33 |
| 45 | 40 | 60 |
| 50 | 40 | 60 |
| 55 | 20 | 80 |
| 70 | 20 | 80 |
| 75 | 67 | 33 |
| 85 | 67 | 33 |
Standard stock solution: 0.3 mg/mL of USP Prednicarbate RS in dehydrated alcohol
Standard solution: 30 µg/mL of USP Prednicarbate RS prepared as follows. Transfer 10.0 mL of the Standard stock solution to a 100-mL volumetric flask. Add 15 mL of tetrahydrofuran and 30 mL of Solution B, and dilute with Solution A to volume.
System suitability stock solution 1: 0.3 mg/mL each of USP Prednicarbate Related Compound B RS and USP Prednicarbate Related Compound C RS in dehydrated alcohol
System suitability stock solution 2: Transfer 15 mg of USP Prednicarbate Related Compound A RS to a 50-mL volumetric flask. Add 1.0 mL of System suitability stock solution 1, and dilute with dehydrated alcohol to volume.
System suitability solution: Transfer 10.0 mL of the Standard solution to a volumetric flask. Add 1.0 mL of System suitability stock solution 2, 1 mL of tetrahydrofuran, and 2 mL of acetonitrile. Dilute with Solution A to 20.0 mL.
Sample solution: Transfer the equivalent of 3.0 mg of prednicarbate from a quantity of Cream to a 100-mL volumetric flask. Add 15 mL of tetrahydrofuran, shake vigorously, and allow to stand in an ultrasonic bath until the sample has dissolved. Add 20 mL of dehydrated alcohol, and shake vigorously. Add 20 mL of acetonitrile, and shake vigorously. Immediately dilute with Solution A to volume, and shake vigorously.
Allow to stand in an ice bath for at least 15 min. Shake vigorously, and pass through a folded paper filter. Pass the filtrate through a membrane filter of 0.45-µm pore size.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 243 nm
Column: 4.0-mm × 25-cm; 5-µm packing L1
Column temperature: 40°
Flow rate: 1 mL/min
Injection volume: 60 µL
System suitability
Samples: Standard solution and System suitability solution
Suitability requirements
Resolution: NLT 1.5 between prednicarbate and prednicarbate related compound A, System suitability solution
Tailing factor: 0.7–1.5, Standard solution
Relative standard deviation: NMT 2.0%, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of prednicarbate (C27H36O8) in the portion of Cream taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Prednicarbate RS in the Standard solution (mg/mL)
CU = nominal concentration of prednicarbate in the Sample solution (mg/mL)
Acceptance criteria: 90.0%–110.0%
4 IMPURITIES
4.1 Organic Impurities
Solution A, Solution B, System suitability stock solution 1, System suitability stock solution 2, Mobile phase, Standard stock solution,
Standard solution, System suitability solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay.
Sensitivity solution: 0.03 µg/mL of USP Prednicarbate RS prepared as follows. Dilute 1.0 mL of the Standard solution with dehydrated alcohol to 50.0 mL. Dilute 1.0 mL of the resulting solution with Solution A to 20.0 mL.
System suitability
Samples: Standard solution, System suitability solution, Sensitivity solution
Suitability requirements
Resolution: NLT 1.5 between prednicarbate and prednicarbate related compound A, System suitability solution
Tailing factor: 0.7-1.5, Standard solution
Relative standard deviation: NMT 2.0%, Standard solution
Signal-to-noise ratio: NLT 3, Sensitivity solution
Analysis
Sample: Sample solution
Calculate the percentage of each related compound and unknown impurity in the portion of Cream taken:
Result = (rU/rT) × 100
rU = peak response for each individual impurity
rT = sum of all the peak responses
Acceptance criteria: See Table 2.
Table 2
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
| Prednicarbate related compound B | 0.57 | 2.0 |
| Prednicarbate related compound C | 0.64 | 2.0 |
| Prednicarbate | 1.00 | - |
| Prednicarbate related compound A | 1.04 | - |
| Any individual related compound | - | 0.5 |
| Total impurities | - | 5.0 |
5 PERFORMANCE TESTS
Minimum Fill: Meets the requirements
6 SPECIFIC TESTS
Consistency: At room temperature, a string of Cream having a length of 2 cm retains its shape on a glass plate for at least 10 min. It can be spread easily and has no visible lumps.
Microbial Enumeration Tests 〈61〉 and Tests for Specified Microorganisms 〈62〉: It meets the requirements of the tests for the absence of Staphylococcus aureus and Pseudomonas aeruginosa. The total aerobic bacterial count does not exceed 10² cfu/g.
pH 〈791〉
Sample solution: Add 15 mL of boiling water to 3.5 g of Cream in a 50-mL centrifuge tube, and shake vigorously until an emulsion is formed. Loosen the cap, and place in a steam bath for 5 min. Centrifuge the hot solution. After cooling to room temperature, collect the lower aqueous solution in a glass tube.
Acceptance criteria: 3.5–5.0
7 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight, light-resistant containers, and store at controlled room temperature.
USP Reference Standards 〈11〉
USP Prednicarbate RS
USP Prednicarbate Related Compound A RS
1,2-Dihydroprednicarbate.
USP Prednicarbate Related Compound B RS
Prednisolone-17-ethylcarbonate.
USP Prednicarbate Related Compound C RS
Prednisolone-21-propionate.

